TurboAC and safety assurance
Following FDA CDRH OSEL’s introduction of safety assurance cases for infusion pumps in 2010, GessNet proposed and developed TurboAC in 2011 through close communication with OSEL. Early manufacturer adoption followed, along with FDA- and AAMI-related education and broader risk-management work for medical devices and combination products.

